Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Congress Wealth Management LLC DE grew its position in Prestige Consumer Healthcare by 246.1% during the fourth quarter. Congress Wealth Management LLC DE now owns 114,220 shares of the company’s stock valued at $6,993,000 after buying an additional 81,215 shares during the period. The Manufacturers Life Insurance Company grew its position in shares of Prestige Consumer Healthcare by 5.3% in the fourth quarter. The Manufacturers Life Insurance Company now owns 605,376 shares of the company’s stock valued at $37,061,000 after purchasing an additional 30,288 shares during the period. Congress Asset Management Co. MA grew its position in shares of Prestige Consumer Healthcare by 596.2% in the fourth quarter. Congress Asset Management Co. MA now owns 679,256 shares of the company’s stock valued at $41,584,000 after purchasing an additional 581,685 shares during the period. Truist Financial Corp boosted its position in Prestige Consumer Healthcare by 54.1% during the fourth quarter. Truist Financial Corp now owns 6,558 shares of the company’s stock worth $401,000 after acquiring an additional 2,302 shares during the last quarter. Finally, Norges Bank acquired a new position in Prestige Consumer Healthcare during the fourth quarter worth about $27,739,000. Institutional investors and hedge funds own 99.95% of the company’s stock.
Analyst Ratings Changes
A number of research firms recently weighed in on PBH. Canaccord Genuity Group restated a “buy” rating and set a $80.00 price target on shares of Prestige Consumer Healthcare in a research report on Tuesday, May 21st. DA Davidson upgraded shares of Prestige Consumer Healthcare from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $65.00 to $93.00 in a research report on Friday, June 21st. Finally, StockNews.com lowered shares of Prestige Consumer Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, May 21st. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Prestige Consumer Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $98.25.
Check Out Our Latest Stock Report on Prestige Consumer Healthcare
Prestige Consumer Healthcare Price Performance
Shares of PBH stock opened at $68.23 on Tuesday. The company has a debt-to-equity ratio of 0.68, a current ratio of 3.20 and a quick ratio of 2.02. The firm’s 50-day moving average is $66.89 and its two-hundred day moving average is $67.02. Prestige Consumer Healthcare Inc. has a 12 month low of $56.34 and a 12 month high of $75.31. The company has a market capitalization of $3.41 billion, a PE ratio of 16.36, a price-to-earnings-growth ratio of 1.93 and a beta of 0.49.
Prestige Consumer Healthcare (NYSE:PBH – Get Free Report) last released its quarterly earnings results on Tuesday, May 14th. The company reported $1.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.14 by ($0.12). The company had revenue of $277.00 million during the quarter, compared to analysts’ expectations of $287.42 million. Prestige Consumer Healthcare had a net margin of 18.60% and a return on equity of 13.48%. Prestige Consumer Healthcare’s revenue was down 3.1% on a year-over-year basis. During the same period last year, the firm posted $1.07 earnings per share. Analysts predict that Prestige Consumer Healthcare Inc. will post 4.42 earnings per share for the current year.
Prestige Consumer Healthcare Company Profile
(Free Report)
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.
Further Reading
Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc. (NYSE:PBH – Free Report).
Receive News & Ratings for Prestige Consumer Healthcare Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com’s FREE daily email newsletter.
link